System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Firdausi Qadri

Infectiology — International Centre for Diarrhoeal Disease Research, Bangladesh

LeadR Profile

Firdausi Qadri International Centre for Diarrhoeal Disease Research Bangladesh
2 823 ScienceLeadR Reputation 2823

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Public Health - Immunology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Firdausi Qadri, Senior Scientist, Infectious Diseases Division and Head, Mucosal Immunology and Vaccinology Unit, at icddr,b, Dhaka, Bangladesh. She is also the founder and leads to Institute for Developing Science and Health Initiatives (ideSHi). Her work includes basic and applied immunology of infectious diseases but also clinical trials and large field-based studies on vaccines. Dr. Qadri has been honored with numerous prestigious awards for her contribution to research. Such as the Gold Medal in Biological Sciences from the Bangladesh Academy of Science, Moselio Schaechter Award by the American Society for Microbiology (ASM), the Christophe & Rodolphe Mérieux Foundation Prize, the French Academy of Sciences, Prof. C.N.R. Rao Prize from TWAS. L'Oréal-UNESCO- For Women in Science Award, Ramon Magsaysay Award 2021- known as Asia’s Nobel Prize. Dr. Qadri received the country's highest award for outstanding contributions to research and training, the Independence Award (Swadhinata Padak) in 2023. It is a unique milestone for women scientists, In 2024, Dr Firdausi Qadri received the prestigious Clara Southmayd Ludlow Medal from the ASTMH and VinFuture Prize from Viet Nam for her pioneering and inspirational contributions to the global health.


Organizations

Career arc: 1988 - 2026
Source: PubMed

International Centre for Diarrhoeal Disease Research

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 747

Citations

Citations: 40 359 1st author: 57 Last author: 162 Unique author: 0

Main journals

PLoS Negl Trop Dis 51
Vaccine 51
Infect Immun 34
J Infect Dis 32
J Clin Microbiol 27

Best Journals

N Engl J Med 5
Lancet 4
Nature 4

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Understanding the Propensity of ETEC Diarrhea in Endemic Settings-A Review of Epidemiological and Immunological Factors and Vaccine-Related Preventive Measures Using a Multisectoral Approach.
epidemiology, vaccines, enterotoxigenic escherichia coli, immunologic factors, public health, immunity, immunity, innate, diarrhea, vaccine development		Microorganisms20260
Perspectives on antibiotic stewardship in the management of diarrhoea among children under five in Bangladesh: insights from clinicians and caregivers.
epidemiology, caregivers, antimicrobial stewardship, social sciences, pediatrics, physical exertion, education, child		J Biosoc Sci20260
Fecal biomarkers to characterize intestinal inflammation among children with medically attended Diarrhea across six low-resource settings: Findings from the enterics for global health (EFGH) Shigella surveillance study.
hemoglobins, blood, leukocyte l1 antigen complex, global health, dysentery, tropical medicine, biomarkers, vomiting, peroxidase, diarrhea, shigella, child		PLoS Negl Trop Dis20260
High exposure, rapid turnover: strain-level dynamics of Klebsiella pneumoniae carriage in community and hospitalized populations in Bangladesh.
genes, antibodies, pharmaceutical preparations, carrier state, klebsiella, klebsiella pneumoniae		Microbiol Spectr20260
Species-specific prophage induction by ciprofloxacin in human gut metagenomes.
cells, genes, virion, ciprofloxacin, genome, prophages, bacteriophages, metagenomics, metagenome, bacteria, gastrointestinal microbiome		mSystems20260

Clinical Studies 33

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Chair: 1 Study Director: 2

By phase:

N/A 11
Phase 3 8
Phase 2 5
Phase 1/Phase 2 3
Phase 1 2
Phase 2/Phase 3 2
Phase 4 2

By status:

Completed 25
Recruiting 2
Terminated 2
Unknown 2
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 31
Observational 2

By Monocentric/Multicentric:

monocentric 27
multicentric2to4 5
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Cholera Control by Case area Targeted Interventions (CATIs)
NCT07685574 — cholera vaccines, vaccines, pharmaceutical preparations, cholera		N/ARecruiting2024
Non interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9 12 Months
NCT06815835 — yellow fever vaccine, rubella vaccine, immunization, safety, blood, vaccines, rubella, measles, vaccination, aged, drug-related side effects and adverse reactions, vaccines, attenuated, yellow fever, infant		Phase 3Not yet recruiting2025
Vaccine and Infection derived Correlates of Protection for Cholera
NCT06455852 — antibody formation, typhoid fever, cholera vaccines, vaccines, vaccines, conjugate, vaccination, cholera, immunity, infections		N/ARecruiting2025
Enterics for Global Health (EFGH)
NCT06047821 — epidemiology, vaccines, incidence, global health, dysentery, dysentery, bacillary, aged, diarrhea, shigella, child		N/AActive not recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS